Search

23 Oct 2020: Share:. The Hauser Forum – a new focal point for entrepreneurship in the region – was today opened by HRH the Duke of Edinburgh, Chancellor of the University of Cambridge. ... Made possible by a major £8m benefaction from the Hauser-Raspe Foundation,

8 Jul 2024: A programme for social scientists developing an entrepreneurial approach with potential to convert research into real-world impact.

8 Jul 2024: href="https://www.enterprise.cam.ac.uk"Cambridge Enterprise/a./p https://www.enterprise.cam.ac.uk/news/new-type-of-computer-memory-could-greatly-reduce-energy-use-and-improve-performance/ ... ac.uk/?post_type=news&p=25805 pThe post a

23 Oct 2020: It is expected that many of these new methods of interacting with a feature phone will eventually migrate upwards into the smartphone market. ... Giovanni Bisutti, CEOof InputDynamics, said “The latest support from Cambridge Enterprise demonstrates

9 Feb 2023: Learn more about the journey of Thiscovery and Cambridge Enterprise.

8 Jul 2024: cam.ac.uk/case-studies/using-the-power-to-fight-fake-news/ Ruth Jackson Wed, 14 Apr 2021 09:52:20 0000 Arts, Humanities & Social Sciences Consultancy academic consultancy Cambridge Social ... Viral!: using the power of gaming to fight fake news/a

8 Jul 2024: cam.ac.uk/new-term-new-skills-new-ventures/ Ruth Jackson Thu, 04 Aug 2016 14:49:13 0000 Cambridge Enterprise Technology Transfer commercialisation events workshops ... We’ve got just the event for you./p pThe post a

8 Jul 2024: Cambridge-based start-up, Wave Photonics, secures £4.5M to advance on-chip photonics for quantum technologies and sensors.

8 Jul 2024: enterprise-ventures/"Introducing Cambridge Enterprise Ventures/a appeared first on a href="https://www.enterprise.cam.ac.uk"Cambridge Enterprise/a./p ... com/?post_type=news&p=7113 pCambridge Innovation Capital plc (CIC), a preferred investor for the

22 Feb 2023: 2 July 2018. Spin-out PredictImmune appoints new CEO. Share:. a developer of pioneering prognostic products for guiding treatment options and improving patient outcomes in immune-mediated diseases, today announced the ... returns. Kinnon takes up his new